Medpace Holdings, Inc. (NASDAQ: MEDP) Stock Competitors & Peer Comparison
See MEDP's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Diagnostics & Research Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for MEDP and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| MEDP | $577.11 | -0.21% | 16.1B | 36.27 | $15.91 | N/A |
| DHR-PB | $1,261.26 | -0.78% | 916.8B | 146.01 | $8.64 | +0.73% |
| TMO | $574.30 | -0.43% | 213.4B | 24.79 | $23.16 | +0.31% |
| DHR | $194.98 | -0.61% | 137.1B | 24.45 | $7.98 | +0.73% |
| IDXX | $559.07 | +0.05% | 44.1B | 41.17 | $13.58 | N/A |
| A | $138.37 | -0.25% | 39.1B | 23.82 | $5.81 | +0.73% |
| IQV | $235.02 | -1.16% | 38.7B | 19.38 | $12.13 | N/A |
| NTRA | $267.76 | -0.70% | 38.3B | -168.40 | -$1.59 | N/A |
| ILMN | $205.10 | +0.00% | 31B | 40.78 | $5.03 | N/A |
| MTD | $1,416.30 | +2.59% | 28.6B | 32.58 | $43.51 | N/A |
Stock Comparison
Danaher Corporation (NYSE: DHR-PB)
MEDP vs DHR-PB Comparison August 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 16.1B. In comparison, DHR-PB has a market cap of 916.8B. Regarding current trading prices, MEDP is priced at $577.11 on the NASDAQ, while DHR-PB trades at $1,261.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.27, whereas DHR-PB's P/E ratio is 146.01. In terms of profitability, MEDP's ROE is +1.10%, compared to DHR-PB's ROE of +0.08%. Regarding short-term risk, MEDP is more volatile compared to DHR-PB. This indicates higher risk in terms of short-term price fluctuations for MEDP.Check DHR-PB's competition here
Thermo Fisher Scientific Inc. (NYSE: TMO)
MEDP vs TMO Comparison August 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 16.1B. In comparison, TMO has a market cap of 213.4B. Regarding current trading prices, MEDP is priced at $577.11 on the NASDAQ, while TMO trades at $574.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.27, whereas TMO's P/E ratio is 24.79. In terms of profitability, MEDP's ROE is +1.10%, compared to TMO's ROE of +0.13%. Regarding short-term risk, MEDP is less volatile compared to TMO. This indicates lower risk in terms of short-term price fluctuations for MEDP.Check TMO's competition here
Danaher Corporation (NYSE: DHR)
MEDP vs DHR Comparison August 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 16.1B. In comparison, DHR has a market cap of 137.1B. Regarding current trading prices, MEDP is priced at $577.11 on the NASDAQ, while DHR trades at $194.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.27, whereas DHR's P/E ratio is 24.45. In terms of profitability, MEDP's ROE is +1.10%, compared to DHR's ROE of +0.08%. Regarding short-term risk, MEDP is less volatile compared to DHR. This indicates lower risk in terms of short-term price fluctuations for MEDP.Check DHR's competition here
IDEXX Laboratories, Inc. (NASDAQ: IDXX)
MEDP vs IDXX Comparison August 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 16.1B. In comparison, IDXX has a market cap of 44.1B. Regarding current trading prices, MEDP is priced at $577.11 on the NASDAQ, while IDXX trades at $559.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.27, whereas IDXX's P/E ratio is 41.17. In terms of profitability, MEDP's ROE is +1.10%, compared to IDXX's ROE of +0.71%. Regarding short-term risk, MEDP is less volatile compared to IDXX. This indicates lower risk in terms of short-term price fluctuations for MEDP.Check IDXX's competition here
Agilent Technologies, Inc. (NYSE: A)
MEDP vs A Comparison August 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 16.1B. In comparison, A has a market cap of 39.1B. Regarding current trading prices, MEDP is priced at $577.11 on the NASDAQ, while A trades at $138.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.27, whereas A's P/E ratio is 23.82. In terms of profitability, MEDP's ROE is +1.10%, compared to A's ROE of +0.21%. Regarding short-term risk, MEDP is less volatile compared to A. This indicates lower risk in terms of short-term price fluctuations for MEDP.Check A's competition here
IQVIA Holdings Inc. (NYSE: IQV)
MEDP vs IQV Comparison August 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 16.1B. In comparison, IQV has a market cap of 38.7B. Regarding current trading prices, MEDP is priced at $577.11 on the NASDAQ, while IQV trades at $235.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.27, whereas IQV's P/E ratio is 19.38. In terms of profitability, MEDP's ROE is +1.10%, compared to IQV's ROE of +0.22%. Regarding short-term risk, MEDP is less volatile compared to IQV. This indicates lower risk in terms of short-term price fluctuations for MEDP.Check IQV's competition here
Natera, Inc. (NASDAQ: NTRA)
MEDP vs NTRA Comparison August 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 16.1B. In comparison, NTRA has a market cap of 38.3B. Regarding current trading prices, MEDP is priced at $577.11 on the NASDAQ, while NTRA trades at $267.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.27, whereas NTRA's P/E ratio is -168.40. In terms of profitability, MEDP's ROE is +1.10%, compared to NTRA's ROE of -0.15%. Regarding short-term risk, MEDP is less volatile compared to NTRA. This indicates lower risk in terms of short-term price fluctuations for MEDP.Check NTRA's competition here
Illumina, Inc. (NASDAQ: ILMN)
MEDP vs ILMN Comparison August 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 16.1B. In comparison, ILMN has a market cap of 31B. Regarding current trading prices, MEDP is priced at $577.11 on the NASDAQ, while ILMN trades at $205.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.27, whereas ILMN's P/E ratio is 40.78. In terms of profitability, MEDP's ROE is +1.10%, compared to ILMN's ROE of +0.31%. Regarding short-term risk, MEDP is less volatile compared to ILMN. This indicates lower risk in terms of short-term price fluctuations for MEDP.Check ILMN's competition here
Mettler-Toledo International Inc. (NYSE: MTD)
MEDP vs MTD Comparison August 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 16.1B. In comparison, MTD has a market cap of 28.6B. Regarding current trading prices, MEDP is priced at $577.11 on the NASDAQ, while MTD trades at $1,416.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.27, whereas MTD's P/E ratio is 32.58. In terms of profitability, MEDP's ROE is +1.10%, compared to MTD's ROE of -12.00%. Regarding short-term risk, MEDP is less volatile compared to MTD. This indicates lower risk in terms of short-term price fluctuations for MEDP.Check MTD's competition here
Quest Diagnostics Incorporated (NYSE: DGX)
MEDP vs DGX Comparison August 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 16.1B. In comparison, DGX has a market cap of 25.7B. Regarding current trading prices, MEDP is priced at $577.11 on the NASDAQ, while DGX trades at $233.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.27, whereas DGX's P/E ratio is 22.98. In terms of profitability, MEDP's ROE is +1.10%, compared to DGX's ROE of +0.14%. Regarding short-term risk, MEDP is more volatile compared to DGX. This indicates higher risk in terms of short-term price fluctuations for MEDP.Check DGX's competition here
Labcorp Holdings Inc. (NYSE: LH)
MEDP vs LH Comparison August 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 16.1B. In comparison, LH has a market cap of 25.4B. Regarding current trading prices, MEDP is priced at $577.11 on the NASDAQ, while LH trades at $309.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.27, whereas LH's P/E ratio is 18.36. In terms of profitability, MEDP's ROE is +1.10%, compared to LH's ROE of +0.12%. Regarding short-term risk, MEDP is less volatile compared to LH. This indicates lower risk in terms of short-term price fluctuations for MEDP.Check LH's competition here
Waters Corporation (NYSE: WAT)
MEDP vs WAT Comparison August 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 16.1B. In comparison, WAT has a market cap of 24.6B. Regarding current trading prices, MEDP is priced at $577.11 on the NASDAQ, while WAT trades at $377.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.27, whereas WAT's P/E ratio is 27.78. In terms of profitability, MEDP's ROE is +1.10%, compared to WAT's ROE of +0.08%. Regarding short-term risk, MEDP is less volatile compared to WAT. This indicates lower risk in terms of short-term price fluctuations for MEDP.Check WAT's competition here
Guardant Health, Inc. (NASDAQ: GH)
MEDP vs GH Comparison August 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 16.1B. In comparison, GH has a market cap of 21.5B. Regarding current trading prices, MEDP is priced at $577.11 on the NASDAQ, while GH trades at $161.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.27, whereas GH's P/E ratio is -62.79. In terms of profitability, MEDP's ROE is +1.10%, compared to GH's ROE of +2.11%. Regarding short-term risk, MEDP is less volatile compared to GH. This indicates lower risk in terms of short-term price fluctuations for MEDP.Check GH's competition here
Exact Sciences Corporation (NASDAQ: EXAS)
MEDP vs EXAS Comparison August 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 16.1B. In comparison, EXAS has a market cap of 20B. Regarding current trading prices, MEDP is priced at $577.11 on the NASDAQ, while EXAS trades at $104.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.27, whereas EXAS's P/E ratio is -95.37. In terms of profitability, MEDP's ROE is +1.10%, compared to EXAS's ROE of -0.09%. Regarding short-term risk, MEDP is more volatile compared to EXAS. This indicates higher risk in terms of short-term price fluctuations for MEDP.Check EXAS's competition here
Illumina, Inc. Common Stock Ex-distribution When-Issued (NASDAQ: ILMNV)
MEDP vs ILMNV Comparison August 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 16.1B. In comparison, ILMNV has a market cap of 17B. Regarding current trading prices, MEDP is priced at $577.11 on the NASDAQ, while ILMNV trades at $107.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.27, whereas ILMNV's P/E ratio is N/A. In terms of profitability, MEDP's ROE is +1.10%, compared to ILMNV's ROE of N/A. Regarding short-term risk, MEDP is more volatile compared to ILMNV. This indicates higher risk in terms of short-term price fluctuations for MEDP.Check ILMNV's competition here
PerkinElmer, Inc. (NYSE: PKI)
MEDP vs PKI Comparison August 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 16.1B. In comparison, PKI has a market cap of 14.5B. Regarding current trading prices, MEDP is priced at $577.11 on the NASDAQ, while PKI trades at $115.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.27, whereas PKI's P/E ratio is 41.45. In terms of profitability, MEDP's ROE is +1.10%, compared to PKI's ROE of +0.03%. Regarding short-term risk, MEDP is more volatile compared to PKI. This indicates higher risk in terms of short-term price fluctuations for MEDP.Check PKI's competition here
Revvity, Inc. (NYSE: RVTY)
MEDP vs RVTY Comparison August 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 16.1B. In comparison, RVTY has a market cap of 12.6B. Regarding current trading prices, MEDP is priced at $577.11 on the NASDAQ, while RVTY trades at $112.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.27, whereas RVTY's P/E ratio is 21.98. In terms of profitability, MEDP's ROE is +1.10%, compared to RVTY's ROE of +0.03%. Regarding short-term risk, MEDP is less volatile compared to RVTY. This indicates lower risk in terms of short-term price fluctuations for MEDP.Check RVTY's competition here
ICON Public Limited Company (NASDAQ: ICLR)
MEDP vs ICLR Comparison August 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 16.1B. In comparison, ICLR has a market cap of 12.5B. Regarding current trading prices, MEDP is priced at $577.11 on the NASDAQ, while ICLR trades at $163.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.27, whereas ICLR's P/E ratio is 13.34. In terms of profitability, MEDP's ROE is +1.10%, compared to ICLR's ROE of +0.04%. Regarding short-term risk, MEDP is less volatile compared to ICLR. This indicates lower risk in terms of short-term price fluctuations for MEDP.Check ICLR's competition here
Charles River Laboratories International, Inc. (NYSE: CRL)
MEDP vs CRL Comparison August 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 16.1B. In comparison, CRL has a market cap of 11.2B. Regarding current trading prices, MEDP is priced at $577.11 on the NASDAQ, while CRL trades at $232.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.27, whereas CRL's P/E ratio is 23.25. In terms of profitability, MEDP's ROE is +1.10%, compared to CRL's ROE of -0.06%. Regarding short-term risk, MEDP is less volatile compared to CRL. This indicates lower risk in terms of short-term price fluctuations for MEDP.Check CRL's competition here
Qiagen N.V. (NYSE: QGEN)
MEDP vs QGEN Comparison August 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 16.1B. In comparison, QGEN has a market cap of 8.5B. Regarding current trading prices, MEDP is priced at $577.11 on the NASDAQ, while QGEN trades at $41.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.27, whereas QGEN's P/E ratio is 17.25. In terms of profitability, MEDP's ROE is +1.10%, compared to QGEN's ROE of +0.11%. Regarding short-term risk, MEDP is more volatile compared to QGEN. This indicates higher risk in terms of short-term price fluctuations for MEDP.Check QGEN's competition here
BillionToOne, Inc. (NASDAQ: BLLN)
MEDP vs BLLN Comparison August 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 16.1B. In comparison, BLLN has a market cap of 6.4B. Regarding current trading prices, MEDP is priced at $577.11 on the NASDAQ, while BLLN trades at $138.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.27, whereas BLLN's P/E ratio is 252.00. In terms of profitability, MEDP's ROE is +1.10%, compared to BLLN's ROE of +0.08%. Regarding short-term risk, MEDP is less volatile compared to BLLN. This indicates lower risk in terms of short-term price fluctuations for MEDP.Check BLLN's competition here
Twist Bioscience Corporation (NASDAQ: TWST)
MEDP vs TWST Comparison August 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 16.1B. In comparison, TWST has a market cap of 5.7B. Regarding current trading prices, MEDP is priced at $577.11 on the NASDAQ, while TWST trades at $91.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.27, whereas TWST's P/E ratio is -42.98. In terms of profitability, MEDP's ROE is +1.10%, compared to TWST's ROE of -0.17%. Regarding short-term risk, MEDP is less volatile compared to TWST. This indicates lower risk in terms of short-term price fluctuations for MEDP.Check TWST's competition here
Sotera Health Company (NASDAQ: SHC)
MEDP vs SHC Comparison August 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 16.1B. In comparison, SHC has a market cap of 5.1B. Regarding current trading prices, MEDP is priced at $577.11 on the NASDAQ, while SHC trades at $17.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.27, whereas SHC's P/E ratio is 19.84. In terms of profitability, MEDP's ROE is +1.10%, compared to SHC's ROE of +0.21%. Regarding short-term risk, MEDP is more volatile compared to SHC. This indicates higher risk in terms of short-term price fluctuations for MEDP.Check SHC's competition here
RadNet, Inc. (NASDAQ: RDNT)
MEDP vs RDNT Comparison August 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 16.1B. In comparison, RDNT has a market cap of 5B. Regarding current trading prices, MEDP is priced at $577.11 on the NASDAQ, while RDNT trades at $63.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.27, whereas RDNT's P/E ratio is 138.65. In terms of profitability, MEDP's ROE is +1.10%, compared to RDNT's ROE of -0.01%. Regarding short-term risk, MEDP is less volatile compared to RDNT. This indicates lower risk in terms of short-term price fluctuations for MEDP.Check RDNT's competition here
Syneos Health, Inc. (NASDAQ: SYNH)
MEDP vs SYNH Comparison August 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 16.1B. In comparison, SYNH has a market cap of 4.5B. Regarding current trading prices, MEDP is priced at $577.11 on the NASDAQ, while SYNH trades at $42.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.27, whereas SYNH's P/E ratio is 61.40. In terms of profitability, MEDP's ROE is +1.10%, compared to SYNH's ROE of +0.08%. Regarding short-term risk, MEDP is more volatile compared to SYNH. This indicates higher risk in terms of short-term price fluctuations for MEDP.Check SYNH's competition here
Veracyte, Inc. (NASDAQ: VCYT)
MEDP vs VCYT Comparison August 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 16.1B. In comparison, VCYT has a market cap of 3.7B. Regarding current trading prices, MEDP is priced at $577.11 on the NASDAQ, while VCYT trades at $46.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.27, whereas VCYT's P/E ratio is 23.16. In terms of profitability, MEDP's ROE is +1.10%, compared to VCYT's ROE of +0.09%. Regarding short-term risk, MEDP is less volatile compared to VCYT. This indicates lower risk in terms of short-term price fluctuations for MEDP.Check VCYT's competition here
Olink Holding AB (publ) (NASDAQ: OLK)
MEDP vs OLK Comparison August 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 16.1B. In comparison, OLK has a market cap of 3.2B. Regarding current trading prices, MEDP is priced at $577.11 on the NASDAQ, while OLK trades at $26.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.27, whereas OLK's P/E ratio is -96.59. In terms of profitability, MEDP's ROE is +1.10%, compared to OLK's ROE of -0.07%. Regarding short-term risk, MEDP is more volatile compared to OLK. This indicates higher risk in terms of short-term price fluctuations for MEDP.Check OLK's competition here
Neogen Corporation (NASDAQ: NEOG)
MEDP vs NEOG Comparison August 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 16.1B. In comparison, NEOG has a market cap of 2.6B. Regarding current trading prices, MEDP is priced at $577.11 on the NASDAQ, while NEOG trades at $12.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.27, whereas NEOG's P/E ratio is 43.00. In terms of profitability, MEDP's ROE is +1.10%, compared to NEOG's ROE of -0.00%. Regarding short-term risk, MEDP is less volatile compared to NEOG. This indicates lower risk in terms of short-term price fluctuations for MEDP.Check NEOG's competition here
CareDx, Inc (NASDAQ: CDNA)
MEDP vs CDNA Comparison August 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 16.1B. In comparison, CDNA has a market cap of 2.3B. Regarding current trading prices, MEDP is priced at $577.11 on the NASDAQ, while CDNA trades at $43.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.27, whereas CDNA's P/E ratio is 52.04. In terms of profitability, MEDP's ROE is +1.10%, compared to CDNA's ROE of +0.33%. Regarding short-term risk, MEDP is less volatile compared to CDNA. This indicates lower risk in terms of short-term price fluctuations for MEDP.Check CDNA's competition here
Personalis, Inc. (NASDAQ: PSNL)
MEDP vs PSNL Comparison August 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 16.1B. In comparison, PSNL has a market cap of 1.4B. Regarding current trading prices, MEDP is priced at $577.11 on the NASDAQ, while PSNL trades at $12.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.27, whereas PSNL's P/E ratio is -12.41. In terms of profitability, MEDP's ROE is +1.10%, compared to PSNL's ROE of -0.44%. Regarding short-term risk, MEDP is less volatile compared to PSNL. This indicates lower risk in terms of short-term price fluctuations for MEDP.Check PSNL's competition here
Castle Biosciences, Inc. (NASDAQ: CSTL)
MEDP vs CSTL Comparison August 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 16.1B. In comparison, CSTL has a market cap of 849.2M. Regarding current trading prices, MEDP is priced at $577.11 on the NASDAQ, while CSTL trades at $28.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.27, whereas CSTL's P/E ratio is -63.64. In terms of profitability, MEDP's ROE is +1.10%, compared to CSTL's ROE of -0.04%. Regarding short-term risk, MEDP is less volatile compared to CSTL. This indicates lower risk in terms of short-term price fluctuations for MEDP.Check CSTL's competition here
GRAIL, Inc. Common Stock (NASDAQ: GRALV)
MEDP vs GRALV Comparison August 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 16.1B. In comparison, GRALV has a market cap of 579.4M. Regarding current trading prices, MEDP is priced at $577.11 on the NASDAQ, while GRALV trades at $18.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.27, whereas GRALV's P/E ratio is N/A. In terms of profitability, MEDP's ROE is +1.10%, compared to GRALV's ROE of N/A. Regarding short-term risk, MEDP is less volatile compared to GRALV. This indicates lower risk in terms of short-term price fluctuations for MEDP.Check GRALV's competition here
Fulgent Genetics, Inc. (NASDAQ: FLGT)
MEDP vs FLGT Comparison August 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 16.1B. In comparison, FLGT has a market cap of 470M. Regarding current trading prices, MEDP is priced at $577.11 on the NASDAQ, while FLGT trades at $16.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.27, whereas FLGT's P/E ratio is 1655.00. In terms of profitability, MEDP's ROE is +1.10%, compared to FLGT's ROE of -0.08%. Regarding short-term risk, MEDP is less volatile compared to FLGT. This indicates lower risk in terms of short-term price fluctuations for MEDP.Check FLGT's competition here
Global Cord Blood Corporation (NYSE: CO)
MEDP vs CO Comparison August 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 16.1B. In comparison, CO has a market cap of 400.1M. Regarding current trading prices, MEDP is priced at $577.11 on the NASDAQ, while CO trades at $2.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.27, whereas CO's P/E ratio is 5.06. In terms of profitability, MEDP's ROE is +1.10%, compared to CO's ROE of +0.11%. Regarding short-term risk, MEDP is less volatile compared to CO. This indicates lower risk in terms of short-term price fluctuations for MEDP.Check CO's competition here
NeoGenomics, Inc. (NASDAQ: NEO)
MEDP vs NEO Comparison August 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 16.1B. In comparison, NEO has a market cap of 392.9M. Regarding current trading prices, MEDP is priced at $577.11 on the NASDAQ, while NEO trades at $15.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.27, whereas NEO's P/E ratio is 117.62. In terms of profitability, MEDP's ROE is +1.10%, compared to NEO's ROE of -0.06%. Regarding short-term risk, MEDP is less volatile compared to NEO. This indicates lower risk in terms of short-term price fluctuations for MEDP.Check NEO's competition here
Prenetics Global Limited (NASDAQ: PRENW)
MEDP vs PRENW Comparison August 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 16.1B. In comparison, PRENW has a market cap of 360.8M. Regarding current trading prices, MEDP is priced at $577.11 on the NASDAQ, while PRENW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.27, whereas PRENW's P/E ratio is N/A. In terms of profitability, MEDP's ROE is +1.10%, compared to PRENW's ROE of -0.47%. Regarding short-term risk, MEDP is more volatile compared to PRENW. This indicates higher risk in terms of short-term price fluctuations for MEDP.Check PRENW's competition here
Prenetics Global Limited (NASDAQ: PRE)
MEDP vs PRE Comparison August 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 16.1B. In comparison, PRE has a market cap of 316.9M. Regarding current trading prices, MEDP is priced at $577.11 on the NASDAQ, while PRE trades at $18.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.27, whereas PRE's P/E ratio is -9.05. In terms of profitability, MEDP's ROE is +1.10%, compared to PRE's ROE of -0.47%. Regarding short-term risk, MEDP is less volatile compared to PRE. This indicates lower risk in terms of short-term price fluctuations for MEDP.Check PRE's competition here
Standard BioTools Inc. (NASDAQ: FLDM)
MEDP vs FLDM Comparison August 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 16.1B. In comparison, FLDM has a market cap of 294.2M. Regarding current trading prices, MEDP is priced at $577.11 on the NASDAQ, while FLDM trades at $3.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.27, whereas FLDM's P/E ratio is -4.74. In terms of profitability, MEDP's ROE is +1.10%, compared to FLDM's ROE of +0.17%. Regarding short-term risk, MEDP is less volatile compared to FLDM. This indicates lower risk in terms of short-term price fluctuations for MEDP.Check FLDM's competition here
Myriad Genetics, Inc. (NASDAQ: MYGN)
MEDP vs MYGN Comparison August 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 16.1B. In comparison, MYGN has a market cap of 270.1M. Regarding current trading prices, MEDP is priced at $577.11 on the NASDAQ, while MYGN trades at $2.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.27, whereas MYGN's P/E ratio is -22.00. In terms of profitability, MEDP's ROE is +1.10%, compared to MYGN's ROE of -0.33%. Regarding short-term risk, MEDP is less volatile compared to MYGN. This indicates lower risk in terms of short-term price fluctuations for MEDP.Check MYGN's competition here
Trinity Biotech plc (NASDAQ: TRIB)
MEDP vs TRIB Comparison August 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 16.1B. In comparison, TRIB has a market cap of 234.9M. Regarding current trading prices, MEDP is priced at $577.11 on the NASDAQ, while TRIB trades at $11.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.27, whereas TRIB's P/E ratio is -3.01. In terms of profitability, MEDP's ROE is +1.10%, compared to TRIB's ROE of +0.68%. Regarding short-term risk, MEDP is less volatile compared to TRIB. This indicates lower risk in terms of short-term price fluctuations for MEDP.Check TRIB's competition here
Biodesix, Inc. (NASDAQ: BDSX)
MEDP vs BDSX Comparison August 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 16.1B. In comparison, BDSX has a market cap of 172.6M. Regarding current trading prices, MEDP is priced at $577.11 on the NASDAQ, while BDSX trades at $21.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.27, whereas BDSX's P/E ratio is -5.22. In terms of profitability, MEDP's ROE is +1.10%, compared to BDSX's ROE of -21.01%. Regarding short-term risk, MEDP is less volatile compared to BDSX. This indicates lower risk in terms of short-term price fluctuations for MEDP.Check BDSX's competition here
Insight Molecular Diagnostics Inc. (NASDAQ: IMDX)
MEDP vs IMDX Comparison August 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 16.1B. In comparison, IMDX has a market cap of 150.1M. Regarding current trading prices, MEDP is priced at $577.11 on the NASDAQ, while IMDX trades at $4.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.27, whereas IMDX's P/E ratio is -3.91. In terms of profitability, MEDP's ROE is +1.10%, compared to IMDX's ROE of +3.81%. Regarding short-term risk, MEDP is less volatile compared to IMDX. This indicates lower risk in terms of short-term price fluctuations for MEDP.Check IMDX's competition here
Genetron Holdings Limited (NASDAQ: GTH)
MEDP vs GTH Comparison August 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 16.1B. In comparison, GTH has a market cap of 127.3M. Regarding current trading prices, MEDP is priced at $577.11 on the NASDAQ, while GTH trades at $4.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.27, whereas GTH's P/E ratio is -1.11. In terms of profitability, MEDP's ROE is +1.10%, compared to GTH's ROE of -1.01%. Regarding short-term risk, MEDP is more volatile compared to GTH. This indicates higher risk in terms of short-term price fluctuations for MEDP.Check GTH's competition here
Genetic Technologies Limited (NASDAQ: GENE)
MEDP vs GENE Comparison August 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 16.1B. In comparison, GENE has a market cap of 111.2M. Regarding current trading prices, MEDP is priced at $577.11 on the NASDAQ, while GENE trades at $0.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.27, whereas GENE's P/E ratio is -38.25. In terms of profitability, MEDP's ROE is +1.10%, compared to GENE's ROE of -1.85%. Regarding short-term risk, MEDP is more volatile compared to GENE. This indicates higher risk in terms of short-term price fluctuations for MEDP.Check GENE's competition here
Exagen Inc. (NASDAQ: XGN)
MEDP vs XGN Comparison August 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 16.1B. In comparison, XGN has a market cap of 109.4M. Regarding current trading prices, MEDP is priced at $577.11 on the NASDAQ, while XGN trades at $4.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.27, whereas XGN's P/E ratio is -6.12. In terms of profitability, MEDP's ROE is +1.10%, compared to XGN's ROE of -1.14%. Regarding short-term risk, MEDP is less volatile compared to XGN. This indicates lower risk in terms of short-term price fluctuations for MEDP.Check XGN's competition here
Sera Prognostics, Inc. (NASDAQ: SERA)
MEDP vs SERA Comparison August 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 16.1B. In comparison, SERA has a market cap of 79.8M. Regarding current trading prices, MEDP is priced at $577.11 on the NASDAQ, while SERA trades at $2.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.27, whereas SERA's P/E ratio is -3.22. In terms of profitability, MEDP's ROE is +1.10%, compared to SERA's ROE of -0.41%. Regarding short-term risk, MEDP is less volatile compared to SERA. This indicates lower risk in terms of short-term price fluctuations for MEDP.Check SERA's competition here
Atlantic International Corp. (NASDAQ: ATLN)
MEDP vs ATLN Comparison August 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 16.1B. In comparison, ATLN has a market cap of 73.2M. Regarding current trading prices, MEDP is priced at $577.11 on the NASDAQ, while ATLN trades at $0.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.27, whereas ATLN's P/E ratio is -0.68. In terms of profitability, MEDP's ROE is +1.10%, compared to ATLN's ROE of +14.94%. Regarding short-term risk, MEDP is less volatile compared to ATLN. This indicates lower risk in terms of short-term price fluctuations for MEDP.Check ATLN's competition here
DarioHealth Corp. (NASDAQ: DRIO)
MEDP vs DRIO Comparison August 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 16.1B. In comparison, DRIO has a market cap of 53.2M. Regarding current trading prices, MEDP is priced at $577.11 on the NASDAQ, while DRIO trades at $7.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.27, whereas DRIO's P/E ratio is -1.24. In terms of profitability, MEDP's ROE is +1.10%, compared to DRIO's ROE of +0.93%. Regarding short-term risk, MEDP is less volatile compared to DRIO. This indicates lower risk in terms of short-term price fluctuations for MEDP.Check DRIO's competition here
Precipio, Inc. (NASDAQ: PRPO)
MEDP vs PRPO Comparison August 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 16.1B. In comparison, PRPO has a market cap of 38.7M. Regarding current trading prices, MEDP is priced at $577.11 on the NASDAQ, while PRPO trades at $21.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.27, whereas PRPO's P/E ratio is -83.27. In terms of profitability, MEDP's ROE is +1.10%, compared to PRPO's ROE of -0.07%. Regarding short-term risk, MEDP is less volatile compared to PRPO. This indicates lower risk in terms of short-term price fluctuations for MEDP.Check PRPO's competition here
Akumin Inc. (NASDAQ: AKU)
MEDP vs AKU Comparison August 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 16.1B. In comparison, AKU has a market cap of 26.3M. Regarding current trading prices, MEDP is priced at $577.11 on the NASDAQ, while AKU trades at $0.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.27, whereas AKU's P/E ratio is -0.13. In terms of profitability, MEDP's ROE is +1.10%, compared to AKU's ROE of -5.32%. Regarding short-term risk, MEDP is less volatile compared to AKU. This indicates lower risk in terms of short-term price fluctuations for MEDP.Check AKU's competition here
MDxHealth S.A. (NASDAQ: MDXH)
MEDP vs MDXH Comparison August 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 16.1B. In comparison, MDXH has a market cap of 21.5M. Regarding current trading prices, MEDP is priced at $577.11 on the NASDAQ, while MDXH trades at $0.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.27, whereas MDXH's P/E ratio is -1.10. In terms of profitability, MEDP's ROE is +1.10%, compared to MDXH's ROE of +4.03%. Regarding short-term risk, MEDP is less volatile compared to MDXH. This indicates lower risk in terms of short-term price fluctuations for MEDP.Check MDXH's competition here
Chembio Diagnostics, Inc. (NASDAQ: CEMI)
MEDP vs CEMI Comparison August 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 16.1B. In comparison, CEMI has a market cap of 16.7M. Regarding current trading prices, MEDP is priced at $577.11 on the NASDAQ, while CEMI trades at $0.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.27, whereas CEMI's P/E ratio is -0.63. In terms of profitability, MEDP's ROE is +1.10%, compared to CEMI's ROE of -0.89%. Regarding short-term risk, MEDP is more volatile compared to CEMI. This indicates higher risk in terms of short-term price fluctuations for MEDP.Check CEMI's competition here
Enzo Biochem, Inc. (NYSE: ENZ)
MEDP vs ENZ Comparison August 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 16.1B. In comparison, ENZ has a market cap of 16.4M. Regarding current trading prices, MEDP is priced at $577.11 on the NASDAQ, while ENZ trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.27, whereas ENZ's P/E ratio is -2.24. In terms of profitability, MEDP's ROE is +1.10%, compared to ENZ's ROE of -0.10%. Regarding short-term risk, MEDP is less volatile compared to ENZ. This indicates lower risk in terms of short-term price fluctuations for MEDP.Check ENZ's competition here
Psychemedics Corporation (NASDAQ: PMD)
MEDP vs PMD Comparison August 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 16.1B. In comparison, PMD has a market cap of 15.6M. Regarding current trading prices, MEDP is priced at $577.11 on the NASDAQ, while PMD trades at $2.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.27, whereas PMD's P/E ratio is -5.24. In terms of profitability, MEDP's ROE is +1.10%, compared to PMD's ROE of -0.32%. Regarding short-term risk, MEDP is more volatile compared to PMD. This indicates higher risk in terms of short-term price fluctuations for MEDP.Check PMD's competition here
23andMe Holding Co. (NASDAQ: ME)
MEDP vs ME Comparison August 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 16.1B. In comparison, ME has a market cap of 15.3M. Regarding current trading prices, MEDP is priced at $577.11 on the NASDAQ, while ME trades at $0.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.27, whereas ME's P/E ratio is -0.03. In terms of profitability, MEDP's ROE is +1.10%, compared to ME's ROE of -42.03%. Regarding short-term risk, MEDP is more volatile compared to ME. This indicates higher risk in terms of short-term price fluctuations for MEDP.Check ME's competition here
Mainz Biomed B.V. (NASDAQ: MYNZ)
MEDP vs MYNZ Comparison August 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 16.1B. In comparison, MYNZ has a market cap of 14.7M. Regarding current trading prices, MEDP is priced at $577.11 on the NASDAQ, while MYNZ trades at $3.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.27, whereas MYNZ's P/E ratio is -0.68. In terms of profitability, MEDP's ROE is +1.10%, compared to MYNZ's ROE of -10.25%. Regarding short-term risk, MEDP is less volatile compared to MYNZ. This indicates lower risk in terms of short-term price fluctuations for MEDP.Check MYNZ's competition here
Quantum Cyber N.V. (NASDAQ: QUCY)
MEDP vs QUCY Comparison August 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 16.1B. In comparison, QUCY has a market cap of 14.3M. Regarding current trading prices, MEDP is priced at $577.11 on the NASDAQ, while QUCY trades at $1.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.27, whereas QUCY's P/E ratio is -0.05. In terms of profitability, MEDP's ROE is +1.10%, compared to QUCY's ROE of -3.26%. Regarding short-term risk, MEDP is less volatile compared to QUCY. This indicates lower risk in terms of short-term price fluctuations for MEDP.Check QUCY's competition here
Bionano Genomics, Inc. (NASDAQ: BNGO)
MEDP vs BNGO Comparison August 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 16.1B. In comparison, BNGO has a market cap of 12.3M. Regarding current trading prices, MEDP is priced at $577.11 on the NASDAQ, while BNGO trades at $1.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.27, whereas BNGO's P/E ratio is -0.24. In terms of profitability, MEDP's ROE is +1.10%, compared to BNGO's ROE of -0.71%. Regarding short-term risk, MEDP is less volatile compared to BNGO. This indicates lower risk in terms of short-term price fluctuations for MEDP.Check BNGO's competition here
Check-Cap Ltd. (NASDAQ: CHEK)
MEDP vs CHEK Comparison August 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 16.1B. In comparison, CHEK has a market cap of 10.9M. Regarding current trading prices, MEDP is priced at $577.11 on the NASDAQ, while CHEK trades at $1.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.27, whereas CHEK's P/E ratio is -0.43. In terms of profitability, MEDP's ROE is +1.10%, compared to CHEK's ROE of -2.26%. Regarding short-term risk, MEDP is less volatile compared to CHEK. This indicates lower risk in terms of short-term price fluctuations for MEDP.Check CHEK's competition here
Centogene N.V. (NASDAQ: CNTG)
MEDP vs CNTG Comparison August 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 16.1B. In comparison, CNTG has a market cap of 9.4M. Regarding current trading prices, MEDP is priced at $577.11 on the NASDAQ, while CNTG trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.27, whereas CNTG's P/E ratio is -0.23. In terms of profitability, MEDP's ROE is +1.10%, compared to CNTG's ROE of +3.98%. Regarding short-term risk, MEDP is more volatile compared to CNTG. This indicates higher risk in terms of short-term price fluctuations for MEDP.Check CNTG's competition here
Burning Rock Biotech Limited (NASDAQ: BNR)
MEDP vs BNR Comparison August 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 16.1B. In comparison, BNR has a market cap of 9.3M. Regarding current trading prices, MEDP is priced at $577.11 on the NASDAQ, while BNR trades at $8.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.27, whereas BNR's P/E ratio is -10.73. In terms of profitability, MEDP's ROE is +1.10%, compared to BNR's ROE of -0.11%. Regarding short-term risk, MEDP is more volatile compared to BNR. This indicates higher risk in terms of short-term price fluctuations for MEDP.Check BNR's competition here
Advanced Biomed Inc. Common Stock (NASDAQ: ADVB)
MEDP vs ADVB Comparison August 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 16.1B. In comparison, ADVB has a market cap of 8.7M. Regarding current trading prices, MEDP is priced at $577.11 on the NASDAQ, while ADVB trades at $8.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.27, whereas ADVB's P/E ratio is -72.73. In terms of profitability, MEDP's ROE is +1.10%, compared to ADVB's ROE of -0.21%. Regarding short-term risk, MEDP is less volatile compared to ADVB. This indicates lower risk in terms of short-term price fluctuations for MEDP.Check ADVB's competition here
Check-Cap Ltd. Ordinary Share (NASDAQ: MBAI)
MEDP vs MBAI Comparison August 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 16.1B. In comparison, MBAI has a market cap of 7.4M. Regarding current trading prices, MEDP is priced at $577.11 on the NASDAQ, while MBAI trades at $1.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.27, whereas MBAI's P/E ratio is 1.58. In terms of profitability, MEDP's ROE is +1.10%, compared to MBAI's ROE of +4.17%. Regarding short-term risk, MEDP is less volatile compared to MBAI. This indicates lower risk in terms of short-term price fluctuations for MEDP.Check MBAI's competition here
Applied DNA Sciences, Inc. (NASDAQ: APDN)
MEDP vs APDN Comparison August 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 16.1B. In comparison, APDN has a market cap of 7.3M. Regarding current trading prices, MEDP is priced at $577.11 on the NASDAQ, while APDN trades at $5.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.27, whereas APDN's P/E ratio is -0.10. In terms of profitability, MEDP's ROE is +1.10%, compared to APDN's ROE of -6.53%. Regarding short-term risk, MEDP is less volatile compared to APDN. This indicates lower risk in terms of short-term price fluctuations for MEDP.Check APDN's competition here
Invitae Corporation (NYSE: NVTA)
MEDP vs NVTA Comparison August 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 16.1B. In comparison, NVTA has a market cap of 5.4M. Regarding current trading prices, MEDP is priced at $577.11 on the NASDAQ, while NVTA trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.27, whereas NVTA's P/E ratio is -0.00. In terms of profitability, MEDP's ROE is +1.10%, compared to NVTA's ROE of -2.02%. Regarding short-term risk, MEDP is less volatile compared to NVTA. This indicates lower risk in terms of short-term price fluctuations for MEDP.Check NVTA's competition here
LumiraDx Limited (NASDAQ: LMDX)
MEDP vs LMDX Comparison August 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 16.1B. In comparison, LMDX has a market cap of 5.1M. Regarding current trading prices, MEDP is priced at $577.11 on the NASDAQ, while LMDX trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.27, whereas LMDX's P/E ratio is -0.01. In terms of profitability, MEDP's ROE is +1.10%, compared to LMDX's ROE of -15.58%. Regarding short-term risk, MEDP is less volatile compared to LMDX. This indicates lower risk in terms of short-term price fluctuations for MEDP.Check LMDX's competition here
LumiraDx Limited (NASDAQ: LMDXW)
MEDP vs LMDXW Comparison August 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 16.1B. In comparison, LMDXW has a market cap of 5.1M. Regarding current trading prices, MEDP is priced at $577.11 on the NASDAQ, while LMDXW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.27, whereas LMDXW's P/E ratio is -0.00. In terms of profitability, MEDP's ROE is +1.10%, compared to LMDXW's ROE of -15.58%. Regarding short-term risk, MEDP is less volatile compared to LMDXW. This indicates lower risk in terms of short-term price fluctuations for MEDP.Check LMDXW's competition here
ENDRA Life Sciences Inc. (NASDAQ: NDRA)
MEDP vs NDRA Comparison August 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 16.1B. In comparison, NDRA has a market cap of 3.6M. Regarding current trading prices, MEDP is priced at $577.11 on the NASDAQ, while NDRA trades at $4.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.27, whereas NDRA's P/E ratio is -0.61. In terms of profitability, MEDP's ROE is +1.10%, compared to NDRA's ROE of -5.13%. Regarding short-term risk, MEDP is less volatile compared to NDRA. This indicates lower risk in terms of short-term price fluctuations for MEDP.Check NDRA's competition here
DermTech, Inc. (NASDAQ: DMTK)
MEDP vs DMTK Comparison August 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 16.1B. In comparison, DMTK has a market cap of 3.3M. Regarding current trading prices, MEDP is priced at $577.11 on the NASDAQ, while DMTK trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.27, whereas DMTK's P/E ratio is -0.04. In terms of profitability, MEDP's ROE is +1.10%, compared to DMTK's ROE of -1.06%. Regarding short-term risk, MEDP is less volatile compared to DMTK. This indicates lower risk in terms of short-term price fluctuations for MEDP.Check DMTK's competition here
bioAffinity Technologies, Inc. (NASDAQ: BIAF)
MEDP vs BIAF Comparison August 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 16.1B. In comparison, BIAF has a market cap of 2.8M. Regarding current trading prices, MEDP is priced at $577.11 on the NASDAQ, while BIAF trades at $0.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.27, whereas BIAF's P/E ratio is -0.07. In terms of profitability, MEDP's ROE is +1.10%, compared to BIAF's ROE of -3.59%. Regarding short-term risk, MEDP is less volatile compared to BIAF. This indicates lower risk in terms of short-term price fluctuations for MEDP.Check BIAF's competition here
Inotiv, Inc. (NASDAQ: NOTV)
MEDP vs NOTV Comparison August 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 16.1B. In comparison, NOTV has a market cap of 2.8M. Regarding current trading prices, MEDP is priced at $577.11 on the NASDAQ, while NOTV trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.27, whereas NOTV's P/E ratio is -0.03. In terms of profitability, MEDP's ROE is +1.10%, compared to NOTV's ROE of -0.75%. Regarding short-term risk, MEDP is less volatile compared to NOTV. This indicates lower risk in terms of short-term price fluctuations for MEDP.Check NOTV's competition here
SeqLL Inc. (NASDAQ: SQL)
MEDP vs SQL Comparison August 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 16.1B. In comparison, SQL has a market cap of 2.5M. Regarding current trading prices, MEDP is priced at $577.11 on the NASDAQ, while SQL trades at $6.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.27, whereas SQL's P/E ratio is -0.40. In terms of profitability, MEDP's ROE is +1.10%, compared to SQL's ROE of +38.02%. Regarding short-term risk, MEDP is less volatile compared to SQL. This indicates lower risk in terms of short-term price fluctuations for MEDP.Check SQL's competition here
Aspira Women's Health Inc. (NASDAQ: AWH)
MEDP vs AWH Comparison August 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 16.1B. In comparison, AWH has a market cap of 2.5M. Regarding current trading prices, MEDP is priced at $577.11 on the NASDAQ, while AWH trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.27, whereas AWH's P/E ratio is -0.09. In terms of profitability, MEDP's ROE is +1.10%, compared to AWH's ROE of +2.03%. Regarding short-term risk, MEDP is more volatile compared to AWH. This indicates higher risk in terms of short-term price fluctuations for MEDP.Check AWH's competition here
Intelligent Bio Solutions Inc. (NASDAQ: INBS)
MEDP vs INBS Comparison August 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 16.1B. In comparison, INBS has a market cap of 1.2M. Regarding current trading prices, MEDP is priced at $577.11 on the NASDAQ, while INBS trades at $1.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.27, whereas INBS's P/E ratio is -0.21. In terms of profitability, MEDP's ROE is +1.10%, compared to INBS's ROE of -1.74%. Regarding short-term risk, MEDP is less volatile compared to INBS. This indicates lower risk in terms of short-term price fluctuations for MEDP.Check INBS's competition here
HTG Molecular Diagnostics, Inc. (NASDAQ: HTGM)
MEDP vs HTGM Comparison August 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 16.1B. In comparison, HTGM has a market cap of 1.1M. Regarding current trading prices, MEDP is priced at $577.11 on the NASDAQ, while HTGM trades at $0.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.27, whereas HTGM's P/E ratio is -0.03. In terms of profitability, MEDP's ROE is +1.10%, compared to HTGM's ROE of -2.73%. Regarding short-term risk, MEDP is more volatile compared to HTGM. This indicates higher risk in terms of short-term price fluctuations for MEDP.Check HTGM's competition here
Biocept, Inc. (NASDAQ: BIOC)
MEDP vs BIOC Comparison August 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 16.1B. In comparison, BIOC has a market cap of 450.8K. Regarding current trading prices, MEDP is priced at $577.11 on the NASDAQ, while BIOC trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.27, whereas BIOC's P/E ratio is -0.01. In terms of profitability, MEDP's ROE is +1.10%, compared to BIOC's ROE of -1.38%. Regarding short-term risk, MEDP is less volatile compared to BIOC. This indicates lower risk in terms of short-term price fluctuations for MEDP.Check BIOC's competition here
iSpecimen Inc. (NASDAQ: ISPC)
MEDP vs ISPC Comparison August 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 16.1B. In comparison, ISPC has a market cap of 262.4K. Regarding current trading prices, MEDP is priced at $577.11 on the NASDAQ, while ISPC trades at $1.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.27, whereas ISPC's P/E ratio is -0.06. In terms of profitability, MEDP's ROE is +1.10%, compared to ISPC's ROE of -5.85%. Regarding short-term risk, MEDP is less volatile compared to ISPC. This indicates lower risk in terms of short-term price fluctuations for MEDP.Check ISPC's competition here
SeqLL Inc. (NASDAQ: SQLLW)
MEDP vs SQLLW Comparison August 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 16.1B. In comparison, SQLLW has a market cap of 179.6K. Regarding current trading prices, MEDP is priced at $577.11 on the NASDAQ, while SQLLW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.27, whereas SQLLW's P/E ratio is -0.00. In terms of profitability, MEDP's ROE is +1.10%, compared to SQLLW's ROE of +38.02%. Regarding short-term risk, MEDP is less volatile compared to SQLLW. This indicates lower risk in terms of short-term price fluctuations for MEDP.Check SQLLW's competition here
Check-Cap Ltd (NASDAQ: CHEKZ)
MEDP vs CHEKZ Comparison August 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 16.1B. In comparison, CHEKZ has a market cap of 0. Regarding current trading prices, MEDP is priced at $577.11 on the NASDAQ, while CHEKZ trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.27, whereas CHEKZ's P/E ratio is N/A. In terms of profitability, MEDP's ROE is +1.10%, compared to CHEKZ's ROE of +4.17%. Regarding short-term risk, MEDP is less volatile compared to CHEKZ. This indicates lower risk in terms of short-term price fluctuations for MEDP.Check CHEKZ's competition here
23andMe Holding Co. (NASDAQ: MEUSW)
MEDP vs MEUSW Comparison August 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 16.1B. In comparison, MEUSW has a market cap of 0. Regarding current trading prices, MEDP is priced at $577.11 on the NASDAQ, while MEUSW trades at $1.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.27, whereas MEUSW's P/E ratio is N/A. In terms of profitability, MEDP's ROE is +1.10%, compared to MEUSW's ROE of -42.03%. Regarding short-term risk, MEDP is less volatile compared to MEUSW. This indicates lower risk in terms of short-term price fluctuations for MEDP.Check MEUSW's competition here
PAREXEL Intl Corp. (NASDAQ: PRXL)
MEDP vs PRXL Comparison August 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 16.1B. In comparison, PRXL has a market cap of 0. Regarding current trading prices, MEDP is priced at $577.11 on the NASDAQ, while PRXL trades at $88.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.27, whereas PRXL's P/E ratio is 42.97. In terms of profitability, MEDP's ROE is +1.10%, compared to PRXL's ROE of +0.17%. Regarding short-term risk, MEDP is more volatile compared to PRXL. This indicates higher risk in terms of short-term price fluctuations for MEDP.Check PRXL's competition here
Danaher Corporation (NYSE: DHR-PA)
MEDP vs DHR-PA Comparison August 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 16.1B. In comparison, DHR-PA has a market cap of 0. Regarding current trading prices, MEDP is priced at $577.11 on the NASDAQ, while DHR-PA trades at $1,841.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.27, whereas DHR-PA's P/E ratio is 233.57. In terms of profitability, MEDP's ROE is +1.10%, compared to DHR-PA's ROE of +0.08%. Regarding short-term risk, MEDP is less volatile compared to DHR-PA. This indicates lower risk in terms of short-term price fluctuations for MEDP.Check DHR-PA's competition here
Ortho Clinical Diagnostics Holdings plc (NASDAQ: OCDX)
MEDP vs OCDX Comparison August 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 16.1B. In comparison, OCDX has a market cap of 0. Regarding current trading prices, MEDP is priced at $577.11 on the NASDAQ, while OCDX trades at $17.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.27, whereas OCDX's P/E ratio is -42.28. In terms of profitability, MEDP's ROE is +1.10%, compared to OCDX's ROE of +0.18%. Regarding short-term risk, MEDP is more volatile compared to OCDX. This indicates higher risk in terms of short-term price fluctuations for MEDP.Check OCDX's competition here
ENDRA Life Sciences Inc. Warrants (NASDAQ: NDRAW)
MEDP vs NDRAW Comparison August 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 16.1B. In comparison, NDRAW has a market cap of 0. Regarding current trading prices, MEDP is priced at $577.11 on the NASDAQ, while NDRAW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.27, whereas NDRAW's P/E ratio is N/A. In terms of profitability, MEDP's ROE is +1.10%, compared to NDRAW's ROE of -5.13%. Regarding short-term risk, MEDP is less volatile compared to NDRAW. This indicates lower risk in terms of short-term price fluctuations for MEDP.Check NDRAW's competition here
BioNano Genomics, Inc. WT EXP 082123 (NASDAQ: BNGOW)
MEDP vs BNGOW Comparison August 2026
Medpace Holdings, Inc. (NASDAQ: MEDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MEDP stands at 16.1B. In comparison, BNGOW has a market cap of 0. Regarding current trading prices, MEDP is priced at $577.11 on the NASDAQ, while BNGOW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MEDP currently has a P/E ratio of 36.27, whereas BNGOW's P/E ratio is N/A. In terms of profitability, MEDP's ROE is +1.10%, compared to BNGOW's ROE of -0.71%. Regarding short-term risk, MEDP is less volatile compared to BNGOW. This indicates lower risk in terms of short-term price fluctuations for MEDP.Check BNGOW's competition here